6DUE
Toxoplasma gondii MyoA, a Class-XIV myosin, in the pre-powerstroke state
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRL BEAMLINE BL14-1 |
Synchrotron site | SSRL |
Beamline | BL14-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2017-07-20 |
Detector | MARMOSAIC 325 mm CCD |
Wavelength(s) | 0.987 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 99.250, 96.230, 92.050 |
Unit cell angles | 90.00, 110.98, 90.00 |
Refinement procedure
Resolution | 48.717 - 2.600 |
R-factor | 0.2216 |
Rwork | 0.220 |
R-free | 0.26120 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4byf |
Data reduction software | iMOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX (1.13_2998) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 85.950 | 2.740 |
High resolution limit [Å] | 2.600 | 2.600 |
Rmerge | 0.124 | 0.856 |
Number of reflections | 24306 | 3495 |
<I/σ(I)> | 7.3 | 1.6 |
Completeness [%] | 97.6 | 96.7 |
Redundancy | 3.8 | 3.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 277 | 1:1 protein solution to reservoir solution (22% PEG8000, 200 mM ammonium sulfate, 100 mM MES, pH 6.5), cryoprotectant: reservoir solution + 15% glycerol |